Connection

Elizabeth Garrett-Mayer to Feasibility Studies

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Feasibility Studies.
Elizabeth Garrett-Mayer
Connection Strength
0.064
Feasibility Studies
  1. A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer. Cancer Immunol Res. 2014 Oct; 2(10):949-61.
    View in: PubMed
    Score: 0.024
  2. Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):135-43.
    View in: PubMed
    Score: 0.022
  3. Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. J Clin Oncol. 2009 Jun 10; 27(17):2816-22.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.